COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4,244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med, 2021; 47(1):60-73.
2.
Van AerdeN, Van den BergheG, WilmerA, GosselinkR, HermansG, ConsortiumC. COVID-19 Consortium. Intensive care unit–acquired muscle weakness in COVID-19 patients. Intensive Care Med, 2020; 46(11):2083-2085.
3.
NasaP, AzoulayE, KhannaAK, JainR, GuptaS, JaveriY, et al. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method. Crit Care, 2021; 25(1):106.
4.
HuangC, WangY, LiX, RenL, ZhaoJ, HuY, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395(10223):497-506.
5.
ThomasP, BaldwinC, BissettB, BodenI, GosselinkR, GrangerCL, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother, 2020; 66(2):73-82.
6.
VitaccaM, CaroneM, CliniEM, PaneroniM, LazzeriM, LanzaA, et al. ITS - AIPO, the ARIR, and the SIP/IRS. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respiration, 2020; 99(6):493-499.
7.
SoneS. [Ethical guidelines for clinical trials in medical research involving human subjects]. Gan to Kagaku Ryoho, 2015; 42(8):893-902.
8.
MorrisPE, GoadA, ThompsonC, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med, 2008; 36(8):2238-2243.
9.
RosasIO, BräuN, WatersM, GoRC, HunterBD, BhaganiS, et al. Tocilizumab in hospitalized patients with severe COVID-19 pneumonia. N Engl J Med, 2021; 384(16):1503-1516.
10.
McWilliamsD, WeblinJ, HodsonJ, VeenithT, WhitehouseT, SnelsonC. Rehabilitation levels in patients with COVID-19 admitted to intensive care requiring invasive ventilation. An observational study. Ann Am Thorac Soc, 2021; 18(1):122-129.
11.
LiZ, PengX, ZhuB, ZhangY, XiX. Active mobilization for mechanically ventilated patients: a systematic review. Arch Phys Med Rehabil, 2013; 94(3):551-561.
12.
VitaccaM, PaneroniM, BrunettiG, CarlucciA, BalbiB, SpanevelloA, et al. Characteristics of COVID-19 pneumonia survivors with resting normoxemia and exercise-induced desaturation. Respir Care, 2021; 66(11):1657-1664.
13.
LloydM, CallanderE, SimonsK, KarahaliosA, MaguireG, JanusE, et al. Mobility deterioration during acute pneumonia illness is associated with increased hospital length of stay and health service costs: an observational study. Cardiopulm Phys Ther J, 2021; 32(4):156-166.
14.
LiJ. Rehabilitation management of patients with COVID-19: lessons learned from the first experience in China. Eur J Phys Rehabil Med, 2020; 56(3):335-338.
15.
MedrinalC, PrieurG, BonnevieT, GravierF-E, MayardD, DesmallesE, et al. Muscle weakness, functional capacities, and recovery for COVID-19 ICU survivors. BMC Anesthesiol, 2021; 21(1):64.
